Photo by atikahakhtar from unsplash
1. Gotlib V, Darji J, Bloomfield K et al. Eosinophilic variant of chronic myeloid leukemia with vascular complications. Leuk. Lymphoma 2003; 44: 1609–13. 2. Tefferi A, Gotlib J, Pardanani A.… Click to show full abstract
1. Gotlib V, Darji J, Bloomfield K et al. Eosinophilic variant of chronic myeloid leukemia with vascular complications. Leuk. Lymphoma 2003; 44: 1609–13. 2. Tefferi A, Gotlib J, Pardanani A. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin. Proc. 2010; 85: 158–64. 3. Barbui T, Thiele J, Gisslinger H et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018; 8: 15. 4. Ionescu MA, Murata H, Janin A. Oral mucosa lesions in hypereosinophilic syndrome–an update. Oral Dis. 2008; 14: 115–22. 5. Lakshmi Sundaramurthi V, Prabhavathy D, Somasundaram SV et al. Hypereosinophilic syndrome: cutaneous involvement as the sole manifestation. Indian J. Dermatol. 2011; 56: 107.
Journal Title: Australasian Journal of Dermatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!